Literature DB >> 21796729

Genotype and cardiovascular phenotype correlations with TBX1 in 1,022 velo-cardio-facial/DiGeorge/22q11.2 deletion syndrome patients.

Tingwei Guo1, Donna McDonald-McGinn, Anna Blonska, Alan Shanske, Anne S Bassett, Eva Chow, Mark Bowser, Molly Sheridan, Frits Beemer, Koen Devriendt, Ann Swillen, Jeroen Breckpot, Maria C Digilio, Bruno Marino, Bruno Dallapiccola, Courtney Carpenter, Xin Zheng, Jacob Johnson, Jonathan Chung, Anne Marie Higgins, Nicole Philip, Tony J Simon, Karlene Coleman, Damian Heine-Suner, Jordi Rosell, Wendy Kates, Marcella Devoto, Elizabeth Goldmuntz, Elaine Zackai, Tao Wang, Robert Shprintzen, Beverly Emanuel, Bernice Morrow.   

Abstract

Haploinsufficiency of TBX1, encoding a T-box transcription factor, is largely responsible for the physical malformations in velo-cardio-facial /DiGeorge/22q11.2 deletion syndrome (22q11DS) patients. Cardiovascular malformations in these patients are highly variable, raising the question as to whether DNA variations in the TBX1 locus on the remaining allele of 22q11.2 could be responsible. To test this, a large sample size is needed. The TBX1 gene was sequenced in 360 consecutive 22q11DS patients. Rare and common variations were identified. We did not detect enrichment in rare SNP (single nucleotide polymorphism) number in those with or without a congenital heart defect. One exception was that there was increased number of very rare SNPs between those with normal heart anatomy compared to those with right-sided aortic arch or persistent truncus arteriosus, suggesting potentially protective roles in the SNPs for these phenotype-enrichment groups. Nine common SNPs (minor allele frequency, MAF > 0.05) were chosen and used to genotype the entire cohort of 1,022 22q11DS subjects. We did not find a correlation between common SNPs or haplotypes and cardiovascular phenotype. This work demonstrates that common DNA variations in TBX1 do not explain variable cardiovascular expression in 22q11DS patients, implicating existence of modifiers in other genes on 22q11.2 or elsewhere in the genome.
© 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21796729      PMCID: PMC3196824          DOI: 10.1002/humu.21568

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  73 in total

1.  Haploview: analysis and visualization of LD and haplotype maps.

Authors:  J C Barrett; B Fry; J Maller; M J Daly
Journal:  Bioinformatics       Date:  2004-08-05       Impact factor: 6.937

2.  Dose-dependent interaction of Tbx1 and Crkl and locally aberrant RA signaling in a model of del22q11 syndrome.

Authors:  Deborah L Guris; Gregg Duester; Virginia E Papaioannou; Akira Imamoto
Journal:  Dev Cell       Date:  2006-01       Impact factor: 12.270

3.  Low-copy repeats mediate the common 3-Mb deletion in patients with velo-cardio-facial syndrome.

Authors:  L Edelmann; R K Pandita; B E Morrow
Journal:  Am J Hum Genet       Date:  1999-04       Impact factor: 11.025

4.  Microduplication and triplication of 22q11.2: a highly variable syndrome.

Authors:  Twila M Yobb; Martin J Somerville; Lionel Willatt; Helen V Firth; Karen Harrison; Jennifer MacKenzie; Natasha Gallo; Bernice E Morrow; Lisa G Shaffer; Melanie Babcock; Judy Chernos; Francois Bernier; Kathy Sprysak; Jesse Christiansen; Shelagh Haase; Basil Elyas; Margaret Lilley; Steven Bamforth; Heather E McDermid
Journal:  Am J Hum Genet       Date:  2005-03-30       Impact factor: 11.025

5.  22q11 deletion in DGS/VCFS monozygotic twins with discordant phenotypes.

Authors:  M C Vincent; F Heitz; J Tricoire; G Bourrouillou; E Kuhlein; M Rolland; P Calvas
Journal:  Genet Couns       Date:  1999

6.  HIRA, a mammalian homologue of Saccharomyces cerevisiae transcriptional co-repressors, interacts with Pax3.

Authors:  P Magnaghi; C Roberts; S Lorain; M Lipinski; P J Scambler
Journal:  Nat Genet       Date:  1998-09       Impact factor: 38.330

7.  A molecular pathway revealing a genetic basis for human cardiac and craniofacial defects.

Authors:  H Yamagishi; V Garg; R Matsuoka; T Thomas; D Srivastava
Journal:  Science       Date:  1999-02-19       Impact factor: 47.728

8.  Congenital heart disease in mice deficient for the DiGeorge syndrome region.

Authors:  E A Lindsay; A Botta; V Jurecic; S Carattini-Rivera; Y C Cheah; H M Rosenblatt; A Bradley; A Baldini
Journal:  Nature       Date:  1999-09-23       Impact factor: 49.962

9.  Microarray analysis detects differentially expressed genes in the pharyngeal region of mice lacking Tbx1.

Authors:  Sarah Ivins; Kelly Lammerts van Beuren; Catherine Roberts; Chela James; Elizabeth Lindsay; Antonio Baldini; Paris Ataliotis; Peter J Scambler
Journal:  Dev Biol       Date:  2005-09-15       Impact factor: 3.582

10.  Mutations of UFD1L are not responsible for the majority of cases of DiGeorge Syndrome/velocardiofacial syndrome without deletions within chromosome 22q11.

Authors:  R Wadey; J McKie; C Papapetrou; H Sutherland; F Lohman; J Osinga; I Frohn; R Hofstra; C Meijers; F Amati; E Conti; A Pizzuti; B Dallapiccola; G Novelli; P Scambler
Journal:  Am J Hum Genet       Date:  1999-07       Impact factor: 11.025

View more
  35 in total

1.  New Genetic Insights into Congenital Heart Disease.

Authors:  Stephanie M Ware; John Lynn Jefferies
Journal:  J Clin Exp Cardiolog       Date:  2012-06-15

2.  Enhanced maternal origin of the 22q11.2 deletion in velocardiofacial and DiGeorge syndromes.

Authors:  Maria Delio; Tingwei Guo; Donna M McDonald-McGinn; Elaine Zackai; Sean Herman; Mark Kaminetzky; Anne Marie Higgins; Karlene Coleman; Carolyn Chow; Maria Jalbrzikowski; Maria Jarlbrzkowski; Carrie E Bearden; Alice Bailey; Anders Vangkilde; Line Olsen; Charlotte Olesen; Flemming Skovby; Thomas M Werge; Ludivine Templin; Tiffany Busa; Nicole Philip; Ann Swillen; Joris R Vermeesch; Koen Devriendt; Maude Schneider; Sophie Dahoun; Stephan Eliez; Kelly Schoch; Stephen R Hooper; Vandana Shashi; Joy Samanich; Robert Marion; Therese van Amelsvoort; Erik Boot; Petra Klaassen; Sasja N Duijff; Jacob Vorstman; Tracy Yuen; Candice Silversides; Eva Chow; Anne Bassett; Amos Frisch; Abraham Weizman; Doron Gothelf; Maria Niarchou; Marianne van den Bree; Michael J Owen; Damian Heine Suñer; Jordi Rosell Andreo; Marco Armando; Stefano Vicari; Maria Cristina Digilio; Adam Auton; Wendy R Kates; Tao Wang; Robert J Shprintzen; Beverly S Emanuel; Bernice E Morrow
Journal:  Am J Hum Genet       Date:  2013-02-28       Impact factor: 11.025

3.  Chimeric negative regulation of p14ARF and TBX1 by a t(9;22) translocation associated with melanoma, deafness, and DNA repair deficiency.

Authors:  Xiaohui Tan; Sarah L Anzick; Sikandar G Khan; Takahiro Ueda; Gary Stone; John J Digiovanna; Deborah Tamura; Daniel Wattendorf; David Busch; Carmen C Brewer; Christopher Zalewski; John A Butman; Andrew J Griffith; Paul S Meltzer; Kenneth H Kraemer
Journal:  Hum Mutat       Date:  2013-06-03       Impact factor: 4.878

4.  Implications of COMT long-range interactions on the phenotypic variability of 22q11.2 deletion syndrome.

Authors:  Michael J Zeitz; Paula P Lerner; Ferhat Ay; Eric Van Nostrand; Julia D Heidmann; William S Noble; Andrew R Hoffman
Journal:  Nucleus       Date:  2013-12-05       Impact factor: 4.197

5.  Genetic Studies in Autism.

Authors:  Shruthi Sudarshan; Neerja Gupta; Madhulika Kabra
Journal:  Indian J Pediatr       Date:  2016-03-03       Impact factor: 1.967

6.  Copy-Number Variation of the Glucose Transporter Gene SLC2A3 and Congenital Heart Defects in the 22q11.2 Deletion Syndrome.

Authors:  Elisabeth E Mlynarski; Molly B Sheridan; Michael Xie; Tingwei Guo; Silvia E Racedo; Donna M McDonald-McGinn; Xiaowu Gai; Eva W C Chow; Jacob Vorstman; Ann Swillen; Koen Devriendt; Jeroen Breckpot; Maria Cristina Digilio; Bruno Marino; Bruno Dallapiccola; Nicole Philip; Tony J Simon; Amy E Roberts; Małgorzata Piotrowicz; Carrie E Bearden; Stephan Eliez; Doron Gothelf; Karlene Coleman; Wendy R Kates; Marcella Devoto; Elaine Zackai; Damian Heine-Suñer; Tamim H Shaikh; Anne S Bassett; Elizabeth Goldmuntz; Bernice E Morrow; Beverly S Emanuel
Journal:  Am J Hum Genet       Date:  2015-04-16       Impact factor: 11.025

7.  Identification of a Tbx1/Tbx2/Tbx3 genetic pathway governing pharyngeal and arterial pole morphogenesis.

Authors:  Karim Mesbah; M Sameer Rana; Alexandre Francou; Karel van Duijvenboden; Virginia E Papaioannou; Antoon F Moorman; Robert G Kelly; Vincent M Christoffels
Journal:  Hum Mol Genet       Date:  2011-11-24       Impact factor: 6.150

8.  Overt cleft palate phenotype and TBX1 genotype correlations in velo-cardio-facial/DiGeorge/22q11.2 deletion syndrome patients.

Authors:  Sean B Herman; Tingwei Guo; Donna M McDonald McGinn; Anna Blonska; Alan L Shanske; Anne S Bassett; Eva W C Chow; Mark Bowser; Molly Sheridan; Frits Beemer; Koen Devriendt; Ann Swillen; Jeroen Breckpot; M Cristina Digilio; Bruno Marino; Bruno Dallapiccola; Courtney Carpenter; Xin Zheng; Jacob Johnson; Jonathan Chung; Anne Marie Higgins; Nicole Philip; Tony Simon; Karlene Coleman; Damian Heine-Suner; Jordi Rosell; Wendy Kates; Marcella Devoto; Elaine Zackai; Tao Wang; Robert Shprintzen; Beverly S Emanuel; Bernice E Morrow
Journal:  Am J Med Genet A       Date:  2012-10-03       Impact factor: 2.802

9.  22q11 Gene dosage establishes an adaptive range for sonic hedgehog and retinoic acid signaling during early development.

Authors:  Thomas M Maynard; Deepak Gopalakrishna; Daniel W Meechan; Elizabeth M Paronett; Jason M Newbern; Anthony-Samuel LaMantia
Journal:  Hum Mol Genet       Date:  2012-10-16       Impact factor: 6.150

Review 10.  22q11.2 deletion syndrome.

Authors:  Donna M McDonald-McGinn; Kathleen E Sullivan; Bruno Marino; Nicole Philip; Ann Swillen; Jacob A S Vorstman; Elaine H Zackai; Beverly S Emanuel; Joris R Vermeesch; Bernice E Morrow; Peter J Scambler; Anne S Bassett
Journal:  Nat Rev Dis Primers       Date:  2015-11-19       Impact factor: 52.329

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.